Skip to content
OpenCapital
Get started

DocGo DCGO Share-Based Payment - Unrecognized Cost of Nonvested Awards

Share-Based Payment - Unrecognized Cost of Nonvested Awards at other companies

Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$0-100%
SRT
Strata Critical Medical, Inc. Class A Common StockSRTA
$3.95—
Medline, Inc. logo
Medline, Inc. MDLN
——

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%—
Net margin-62.2%—
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%—
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's share-based payment - unrecognized cost of nonvested awards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's share-based payment - unrecognized cost of nonvested awards?
DocGo (DCGO) reported share-based payment - unrecognized cost of nonvested awards of $2.53M in Q1 2026.
How has DocGo's share-based payment - unrecognized cost of nonvested awards changed year-over-year?
DocGo's share-based payment - unrecognized cost of nonvested awards decreased by 73.1% year-over-year, from $9.42M to $2.53M.
What is the long-term trend for DocGo's share-based payment - unrecognized cost of nonvested awards?
Over 3 years (2022 to 2025), DocGo's share-based payment - unrecognized cost of nonvested awards has grown at a -57.3% compound annual growth rate (CAGR), from $41.67M to $3.25M.
What does share-based payment - unrecognized cost of nonvested awards mean?
This represents the total compensation expense for equity-based awards that has been granted but not yet recognized in the income statement because the vesting conditions have not been met. It serves as a forward-looking indicator of future non-cash compensation expenses. Investors use this to forecast the impact of stock-based compensation on future earnings.